Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles Natanson

Showing results (21-30 of 113) with videos related to

Pageof 12
Sort By:
Critical Care Medicine|February 26, 2025
Sometimes It Is Better to Be LiberalVerity J Ford, Harvey G Klein, Charles Natanson
Critical Care Medicine|November 29, 2007
Separating practice guidelines from pharmaceutical marketingPeter Q Eichacker, Charles Natanson, Robert L Danner
JAMA|September 11, 2015
Red Blood Cell Transfusion: Precision vs Imprecision MedicineHarvey G Klein, Willy A Flegel, Charles Natanson
JAMA|October 22, 2009
Corticosteroid therapy for severe sepsis and septic shockPeter C Minneci, Katherine J Deans, Charles Natanson
British Journal of Haematology|January 28, 2014
Does prolonged storage of red blood cells cause harm?Willy A Flegel, Charles Natanson, Harvey G Klein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2012
Excess deaths associated with tigecycline after approval based on noninferiority trialsParitosh Prasad, Junfeng Sun, Robert L Danner, et al.
Critical Care Medicine|December 22, 2009
Risk of death and the efficacy of eritoran tetrasodium (E5564): design considerations for clinical trials of anti-inflammatory agents in sepsisAmisha V Barochia, Xizhong Cui, Charles Natanson, et al.
Critical Care Medicine|January 25, 2003
Long-term cost effectiveness of drotrecogin alfa (activated): an unanswered questionSteven M Banks, Eric Gerstenberger, Peter Q Eichacker, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 18, 2011
Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studiesAmisha Barochia, Steven Solomon, Xizhong Cui, et al.
Intensive Care Medicine|October 8, 2008
Once is not enough: clinical trials in sepsisDaniel A Sweeney, Robert L Danner, Peter Q Eichacker, et al.
Pageof 12

Showing results (21-30 of 113) with videos related to

Sort By:
Pageof 12
Critical Care Medicine|February 26, 2025
Sometimes It Is Better to Be LiberalVerity J Ford, Harvey G Klein, Charles Natanson
Critical Care Medicine|November 29, 2007
Separating practice guidelines from pharmaceutical marketingPeter Q Eichacker, Charles Natanson, Robert L Danner
JAMA|September 11, 2015
Red Blood Cell Transfusion: Precision vs Imprecision MedicineHarvey G Klein, Willy A Flegel, Charles Natanson
JAMA|October 22, 2009
Corticosteroid therapy for severe sepsis and septic shockPeter C Minneci, Katherine J Deans, Charles Natanson
British Journal of Haematology|January 28, 2014
Does prolonged storage of red blood cells cause harm?Willy A Flegel, Charles Natanson, Harvey G Klein
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 3, 2012
Excess deaths associated with tigecycline after approval based on noninferiority trialsParitosh Prasad, Junfeng Sun, Robert L Danner, et al.
Critical Care Medicine|December 22, 2009
Risk of death and the efficacy of eritoran tetrasodium (E5564): design considerations for clinical trials of anti-inflammatory agents in sepsisAmisha V Barochia, Xizhong Cui, Charles Natanson, et al.
Critical Care Medicine|January 25, 2003
Long-term cost effectiveness of drotrecogin alfa (activated): an unanswered questionSteven M Banks, Eric Gerstenberger, Peter Q Eichacker, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 18, 2011
Eritoran tetrasodium (E5564) treatment for sepsis: review of preclinical and clinical studiesAmisha Barochia, Steven Solomon, Xizhong Cui, et al.
Intensive Care Medicine|October 8, 2008
Once is not enough: clinical trials in sepsisDaniel A Sweeney, Robert L Danner, Peter Q Eichacker, et al.
Pageof 12